Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: A north and south Europe comparison

Annals of the Rheumatic Diseases

Volumn 64, Issue 2, 2005, Pages 212-216

  Cutolo, M ^a   Maestroni, G J M ^b   Otsa, K ^c   Aakre, O ^c   Villaggio, B ^a   Capellino, S ^a   Montagna, P ^a   Fazzuoli, L ^d   Veldi, T ^c   Peets, T ^c   Hertens, E ^b   Sulli, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b INSTITUTE OF PATHOLOGY   (Switzerland)

^c Central Hospital   (Estonia)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 6; IODINE 125; MELATONIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; DISEASE SEVERITY; ESTONIA; EUROPE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ITALY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; WINTER;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; ESTONIA; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; ITALY; MALE; MELATONIN; MIDDLE AGED; PHOTOPERIOD; SEASONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19944432036     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.023416     Document Type: Article

References (35)

1. Straub R, Cutolo M. Impact of the hypothalamic-pituitary-adrenal/gonadal axes and the peripheral nervous system in rheumatoid arthritis: a systemic pathogenic view point. Arthritis Rheum 2001;44:493-507.
2. Petrovsky N, Harrison L. The chronobiology of human cytokine production. Int Rev Immunol 1998;16:635-49.
3. Yu HS, Tsin ATC, Reiter RJ. MLT: history, biosynthesis, and assay methodology. In: Yu HS, Reiter RJ, eds. MLT. Biosynthesis, physiological effects, and clinical applications. Boca Raton: CRC Press, 1993:1-17.
4. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992;49:26-31.
5. Maestroni GJM. The immunotherapeutic potential of MLT. Exp Opin Invet Drugs 2001;10:467-76.
6. Garcia-Maurino S, Gonzales-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R, et al. MLT enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 1997;159:574-81.
7. Petrovsky N, Harrison L. Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type1/T helper cell type 2 balance. J Immunol 1996;158:5163-8.
8. Maestroni GJM. T-helper 2 lymphocytes as a peripheral target of MLT. J Pineal Res 1995;18:84-9.
9. Hansson I, Holmdahl R, Mattsson R. The pineal hormone MLT exaggerates development of collagen-induced arthritis in mice. J Neuroimmunol 1992;39:23-31.
10. Cutolo M, Villaggio B, Candida F, Valenti S, Giusti M, Felli L, et al. MLT influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann NY Acad Sci 1999;876:246-54.
11. Sulli A, Maestroni GJM, Villaggio B, Hertens E, Craviotto C, Pizzorni C, et al. MLT serum levels in rheumatoid arthritis. Ann NY Acad Sci 2002;966:276-83.
12. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000;223:230-3.
13. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
14. Cutolo M, Seriolo B, Craviotto C, Pizzorni C, Sulli A. Circadian rhythms in RA. Ann Rheum Dis 2003;62:593-6.
15. Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni G. Evidence for MLT synthesis in mouse and human bone marrow cells. J Pineal Res 2000;28:193-202.
16. Maestroni G, Sulli A, Pizzorni C, Villaggio B, Cutolo M. MLT in rheumatoid arthritis: a disease promoting and modulating hormone? Clin Exp Rheumatol 2002;20:872-3.
17. Maestroni GJM, Sulli A, Pizzorni C, Villaggio B, Cutolo M. MLT in rheumatoid arthritis: synovial macrophages show MLT receptors. Ann NY Acad Sci 2002;966:271-5.
18. Staples JA, Ponsonby AL, Lim LL, McMichael AJ. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect 2003;111:518-23.
19. Jacoby RK, Jayson MI, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. BMJ, 1973;ii, 96-100.
20. Rozin A, Balbir-Gurman A, Schapira D. Seasonal distribution of relapse onset in rheumatoid arthritis and spondyloarthropothy: the possible effect of solar factor. Clin Exp Rheumatol 2003;21:161-70.
21. Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum 1997;27:123-40.
22. Spector TD. Rheumatoid arthritis. Rheum Dis Clin North Am 1990;16:513-37.
23. Roberts JE. Light and immunomodulation. Ann NY Acad Sci 2000;917:435-45.
24. Miyatake A, Morimoto Y, Uishi T. Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin, and cortisol in normal men. J Clin Endocrinol Metab 1980;51:1365-71.
25. Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to IL-6 and TNF in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002;46:654-62.
26. Dekkers JK, Greenen R, Godaert GLR, van Doornen LJP, Bijlsma LWJ. Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:465-7.
27. Maestroni GJ, Conti A, Pierpaoli W. Role of the pineal gland in immunity: diurnal synthesis and release of MLT modulates the antibody response and antagonizes the immunosuppressive effects of corticosterone. J Neuroimmunol 1986;13:19-26.
28. Masi AT, Chrousos GP. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. J Rheumatol 1996;23:577-81.
29. Maestroni GJ. The immuneneuroendocrine role of MLT. J Pineal Res 1993;14:1-10.
30. Leproult REF, Colecchia M, Hermite-Baleriaux L, Van Cauter E. Transition from dim to bright light in the morning induces an immediate elevotion of cortisol levels. J Clin Endocrinol Metab 2001;86:151-7.
31. Hack LMSW, Lockley J, Arend T, Skene DJ. The effects of low-dose 0.5-mg MLT on the free-running circadian rhythms of blind subjects. J Biol Rhythms 2003;18:420-9.
32. De Rijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, et al. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab 1997;82:2182-91.
33. Ponsonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002;181-2:71-8.
34. Nelsos RJ, Drazen DL. MLT mediates seasonal changes in immune function. Ann NY Acad Sci 2000;917:404-15.
35. Cutolo M. Solar light effects on onset/relapse and circannual/circadian symptomatology in rheumatoid arthritis. Clin Exp Rheum 2003;21:148-50.